SLXNW Silexion Therapeutics Corp - Warrant
$0,01
Kurs · Aug 18, 2026
Fundamentaldaten per Aug 14, 2026
52W-Spanne
$0–$0
1% of range
Analystenbewertung
—
Kursziel
—
P/E (TTM)
0.0
ROE
1718.9%
Nettogewinnmarge
—
SLXNW Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$0.01
Marktkapitalisierung
$4.1K
P/E (TTM)
0.0
EPS (TTM)
$8.96
Umsatz (TTM)
—
Dividendenrendite
—
ROE
1718.9%
Verschuldungsgrad
—
52W-Spanne
$0 – $0
SLXNW Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
—
EPS
$8.96
2023-12-31
→
2025-12-31
Freier Cashflow
$-11M
2024-12-31
→
2025-12-31
Margen
—
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
SLXNW
Peer-Median
P/E (TTM)
0.0
—
P/B (K/B)
0.0
—
Price / FCF (Kurs / FCF)
-0.0
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
SLXNW
Peer-Median
ROA
-236.4%
—
ROE
1718.9%
—
ROIC
-447.0%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
SLXNW
Peer-Median
Current Ratio (Liquiditätsgrad)
2.4
—
Quick Ratio
2.2
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
SLXNW
Peer-Median
EPS YoY (EPS VjV)
-97.7%
—
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
SLXNW
Peer-Median
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 14
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| R&D Expense | $7M | $6M | $4M | |
| SG&A Expense | $4M | $7M | $973.0K | |
| Operating Expenses | $12M | $13M | $5M | |
| Operating Income | $-12M | $-13M | $-5M | |
| Interest Income | $155.0K | $28.0K | $153.0K | |
| Other Non-op | $13.0K | $7.0K | $6.0K | |
| Pretax Income | $-12M | $-17M | $-5M | |
| Income Tax | $3.0K | $10.0K | $32.0K | |
| Net Income | $-12M | $-17M | $-5M | |
| EPS (Basic) | $8.96 | $394.94 | $44.23 | |
| EPS (Diluted) | $8.96 | $394.94 | $44.23 | |
| Shares (Basic) | 1,329,515 | 41,635 | 111,726 | |
| Shares (Diluted) | 1,329,515 | 41,635 | 111,726 | |
| EBITDA | $-12M | $-13M | · |
Bilanz 19
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $6M | $1M | $5M | |
| Prepaid Expense | $570.0K | $966.0K | $335.0K | |
| Other Current Assets | $49.0K | $62.0K | $24.0K | |
| Current Assets | $7M | $2M | $5M | |
| PP&E (Net) | $25.0K | $30.0K | $49.0K | |
| PP&E (Gross) | $108.0K | $99.0K | $133.0K | |
| Accum. Depreciation | $83.0K | $69.0K | $84.0K | |
| Total Assets | $7M | $3M | $5M | |
| Accounts Payable | $787.0K | $929.0K | $319.0K | |
| Accrued Liabilities | $859.0K | · | · | |
| Current Liabilities | $3M | $4M | $2M | |
| Capital Leases | $286.0K | $368.0K | $59.0K | |
| Total Liabilities | $5M | $7M | $2M | |
| Common Stock | $42.0K | $2.0K | · | |
| Paid-in Capital | $58M | $39M | $11M | |
| Retained Earnings | $-55M | $-43M | $-27M | |
| Stockholders' Equity | $3M | $-4M | $-15M | |
| Liabilities + Equity | $7M | $3M | $5M | |
| Shares Outstanding | 312,665 | 123,290,000 | 97,120,000 |
Cashflow 6
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Stock-based Comp | $134.0K | $6M | $130.0K | |
| Operating Cash Flow | $-11M | $-8M | $-5M | |
| CapEx | $9.0K | $22.0K | $12.0K | |
| Investing Cash Flow | $-14.0K | $-22.0K | $573.0K | |
| Financing Cash Flow | $16M | $5M | $522.0K | |
| Free Cash Flow | $-11M | $-8M | · |
Rentabilität 3
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| ROA | -236.4% | -555.3% | · | |
| ROE | 1718.9% | 169.7% | · | |
| ROIC | -447.0% | 315.3% | · |
Liquidität & Solvenz 2
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 2.4 | 0.6 | · | |
| Quick Ratio | 2.2 | 0.3 | · |
Wachstumsraten 1
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| EPS YoY | -97.7% | 792.9% | · |
Bewertung (TTM) 8
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Net Income TTM | $-12M | $-17M | · | |
| Market Cap | $103M | · | · | |
| P/E | 0.0 | · | · | |
| P/B | 39.6 | · | · | |
| P / Tangible Book | 39.6 | · | · | |
| P / Cash Flow | -9.5 | · | · | |
| P / FCF | -9.5 | · | · | |
| Earnings Yield | 27151.5% | · | · |
Gewinn- und Verlustrechnung 14
| Kennzahl | Trend | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $2M | $3M | $2M | $1M | $590.0K | $871.0K | $3M | $766.0K | $961.0K | $1M | $535.0K | $1M | |
| SG&A Expense | $1M | $1M | $1M | $1M | $1M | $1M | $5M | $619.0K | $289.0K | $471.0K | $196.0K | $179.0K | |
| Operating Expenses | $4M | $4M | $3M | $2M | $2M | $2M | $8M | $1M | $1M | $2M | $731.0K | $1M | |
| Operating Income | $-4M | $-4M | $-3M | $-2M | $-2M | $-2M | $-8M | $-1M | $-1M | $-2M | $-731.0K | $-1M | |
| Interest Income | $14.0K | $70.0K | $39.0K | $44.0K | $2.0K | $3.0K | $0 | $6.0K | $19.0K | · | · | · | |
| Other Non-op | $-115.0K | $6.0K | $4.0K | $260.0K | $3.0K | $2.0K | $3.0K | $2.0K | $0 | $1.0K | $1.0K | $3.0K | |
| Pretax Income | $-4M | $-4M | $-3M | $-2M | $-2M | $-2M | $-12M | $-1M | $-1M | $-2M | $-803.0K | $-2M | |
| Income Tax | · | $0 | $0 | $3.0K | · | $1.0K | $2.0K | $2.0K | $5.0K | $6.0K | $6.0K | $10.0K | |
| Net Income | $-4M | $-4M | $-3M | $-3M | $-2M | $-2M | $-12M | $-1M | $-1M | $-2M | $-809.0K | $-2M | |
| EPS (Basic) | $5.17 | $1.50 | $2.88 | $43.19 | $0.26 | $-89.40 | $274.25 | $197.80 | $12.29 | $41.03 | $0.78 | $6.54 | |
| EPS (Diluted) | $5.17 | $1.50 | $2.88 | $43.19 | $0.26 | $-89.40 | $274.25 | $197.80 | $12.29 | $41.03 | $0.78 | $6.54 | |
| Shares (Basic) | 687,353 | -7,161,871 | 1,132,658 | 57,952 | 6,779,205 | -120,746 | 43,213 | 7,442 | 111,726 | -893,805 | 1,005,531 | 252,462 | |
| Shares (Diluted) | 687,353 | -7,161,871 | 1,132,658 | 57,952 | 6,779,205 | -120,746 | 43,213 | 7,442 | 111,726 | -893,805 | 1,005,531 | 252,462 | |
| EBITDA | $-4M | · | $-3M | $-2M | $-2M | · | $-8M | $-1M | · | · | · | · |
Bilanz 19
| Kennzahl | Trend | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2M | $6M | $9M | $3M | $6M | $1M | $2M | $2M | · | $5M | · | · | |
| Prepaid Expense | $1M | $570.0K | $2M | $2M | $1M | $966.0K | $944.0K | $527.0K | · | $335.0K | · | · | |
| Other Current Assets | $111.0K | $49.0K | $47.0K | $63.0K | $58.0K | $62.0K | $80.0K | $66.0K | · | $24.0K | · | · | |
| Current Assets | $4M | $7M | $11M | $5M | $8M | $2M | $3M | $2M | · | $5M | · | · | |
| PP&E (Net) | $20.0K | $25.0K | $26.0K | $30.0K | $32.0K | $30.0K | $35.0K | $40.0K | · | $49.0K | · | · | |
| PP&E (Gross) | · | $108.0K | · | · | · | $99.0K | · | · | · | $133.0K | · | · | |
| Accum. Depreciation | · | $83.0K | · | · | · | $69.0K | · | · | · | $84.0K | · | · | |
| Total Assets | $4M | $7M | $12M | $6M | $8M | $3M | $3M | $3M | · | $5M | · | · | |
| Accounts Payable | · | $787.0K | $946.0K | $692.0K | $722.0K | $929.0K | $799.0K | $281.0K | · | $319.0K | · | · | |
| Accrued Liabilities | $933.0K | · | · | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $4M | $3M | $3M | $2M | $2M | $4M | $4M | $2M | · | $2M | · | · | |
| Capital Leases | $226.0K | $286.0K | $311.0K | $337.0K | $334.0K | $368.0K | $0 | $8.0K | · | $59.0K | · | · | |
| Total Liabilities | $4M | $5M | $5M | $6M | $6M | $7M | $8M | $2M | · | $2M | · | · | |
| Common Stock | $160.0K | $42.0K | $42.0K | $8.0K | $8.0K | $2.0K | $1.0K | $1.0K | · | · | · | · | |
| Paid-in Capital | $61M | $58M | $58M | $48M | $48M | $39M | $37M | $11M | · | $11M | · | · | |
| Retained Earnings | $-61M | $-55M | $-51M | $-47M | $-45M | $-43M | $-42M | $-30M | · | $-27M | · | · | |
| Stockholders' Equity | $44.0K | $3M | $7M | $120.0K | $3M | $-4M | $-5M | $-18M | · | $-15M | · | · | |
| Liabilities + Equity | $4M | $7M | $12M | $6M | $8M | $3M | $3M | $3M | · | $5M | · | · | |
| Shares Outstanding | 1,179,844 | 3,126,651,000 | 3,126,642 | 579,536 | 8,691,971 | 123,290,000 | 11,180,031 | 219,354 | · | 97,120,000 | · | · |
Cashflow 8
| Kennzahl | Trend | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $197.0K | $38.0K | $38.0K | $37.0K | $21.0K | $0 | $6M | $32.0K | $32.0K | $34.0K | $32.0K | $32.0K | |
| Operating Cash Flow | $-3M | $-3M | $-3M | $-3M | $-2M | $-3M | $-3M | $-1M | $-2M | $-1M | $-685.0K | $-2M | |
| CapEx | $0 | $2.0K | $0 | $1.0K | $6.0K | $0 | $16.0K | $0 | $6.0K | $4.0K | $6.0K | $2.0K | |
| Investing Cash Flow | $-1.0K | $-7.0K | $0 | $-1.0K | $-6.0K | $0 | $-16.0K | $0 | $-6.0K | $-4.0K | $72.0K | $-2.0K | |
| Stock Issued | $2M | · | $0 | $0 | · | · | $620.0K | · | · | · | · | · | |
| Net Stock Activity | $2M | · | $0 | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $3M | $-221.0K | $9M | $-195.0K | $7M | $2M | $3M | $0 | · | $0 | $0 | $522.0K | |
| Free Cash Flow | $-3M | · | $-3M | $-3M | $-2M | · | $-3M | · | · | · | · | · |
Rentabilität 3
| Kennzahl | Trend | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -70.7% | · | -44.4% | -60.2% | -41.8% | · | -768.4% | -117.9% | · | · | · | · | |
| ROE | -4330.5% | · | -272.1% | 27.6% | -134.2% | · | 518.0% | 16.3% | · | · | · | · | |
| ROIC | · | · | -47.2% | -1905.6% | · | · | 175.5% | 7.6% | · | · | · | · |
Liquidität & Solvenz 2
| Kennzahl | Trend | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.9 | · | 4.0 | 2.4 | 3.2 | · | 0.9 | 1.0 | · | · | · | · | |
| Quick Ratio | 0.6 | · | 3.3 | 1.6 | 2.6 | · | 0.6 | 0.7 | · | · | · | · |
Bewertung (TTM) 8
| Kennzahl | Trend | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-12M | · | $-19M | $-18M | $-17M | · | $-16M | $-6M | · | · | · | · | |
| Market Cap | $39.4K | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | 0.0 | · | · | · | · | · | · | · | · | · | · | · | |
| P/B | 0.9 | · | · | · | · | · | · | · | · | · | · | · | |
| P / Tangible Book | 0.9 | · | · | · | · | · | · | · | · | · | · | · | |
| P / Cash Flow | -0.0 | · | · | · | · | · | · | · | · | · | · | · | |
| P / FCF | -0.0 | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | 155958.1% | · | · | · | · | · | · | · | · | · | · | · |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2025-06-30 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| Nettoergebnis | $-12M | — | $-17M | — | — |
| Verwässerte EPS | $8.96 | — | $394.94 | — | — |
Bilanz
| 2025-12-31 | 2025-06-30 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| Liquiditätsgrad | 2.4 | — | 0.6 | — | — |
| Quick Ratio | 2.2 | — | 0.3 | — | — |
Cashflow
| 2025-12-31 | 2025-06-30 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| Freier Cashflow | $-11M | — | $-8M | — | — |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 23 Einreicher · $141K gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 1 (+1 vs. Vorquartal) | 1 (-2 vs. Vorquartal) | 1 (0 vs. Vorquartal) | 1 (0 vs. Vorquartal) | +81K |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| DeepCurrents Investment Group LLC | $36.167 | 14.183 | 25,73% | Kaufoption |
| Oasis Management Co Ltd. | $28.333 | 11.111 | 20,16% | Aktien |
| Polar Asset Management Partners Inc. | $20.817 | 743.475 | 14,81% | Aktien |
| Linden Advisors LP | $9.484 | 337.500 | 6,75% | Aktien |
| CLEAR STREET LLC | $8.988 | 219.765 | 6,39% | Aktien |
| ARISTEIA CAPITAL, L.L.C. | $6.635 | 236.546 | 4,72% | Aktien |
| Clear Street Group Inc. | $6.632 | 218.165 | 4,72% | Aktien |
| SECURITY BENEFIT LIFE INSURANCE CO /KS/ | $4.560 | 150.000 | 3,24% | Aktien |
| GOLDMAN SACHS GROUP INC | $3.803 | 125.103 | 2,71% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2.799 | 92.073 | 1,99% | Aktien |
| JANE STREET GROUP, LLC | $2.277 | 74.910 | 1,62% | Aktien |
| PICTON MAHONEY ASSET MANAGEMENT | $1.738 | 57.175 | 1,24% | Aktien |
| Context Capital Management, LLC | $1.556 | 51.183 | 1,11% | Aktien |
| TENOR CAPITAL MANAGEMENT Co., L.P. | $1.520 | 50.000 | 1,08% | Aktien |
| GABELLI & Co INVESTMENT ADVISERS, INC. | $1.160 | 38.150 | 0,83% | Aktien |
| DUPONT CAPITAL MANAGEMENT CORP | $988 | 32.500 | 0,70% | Aktien |
| NEUBERGER BERMAN GROUP LLC | $959 | 31.552 | 0,68% | Aktien |
| GABELLI FUNDS LLC | $927 | 30.496 | 0,66% | Aktien |
| STIFEL FINANCIAL CORP | $486 | 16.000 | 0,35% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $380 | 12.500 | 0,27% | Kaufoption |
| COBBLESTONE CAPITAL ADVISORS LLC /NY/ | $352 | 10.000 | 0,25% | Aktien |
| Kepos Capital LP | $3 | 100.000 | 0,00% | Aktien |
| Mint Tower Capital Management B.V. | $1 | 25.000 | 0,00% | Aktien |
Aktivisten & 5%+-Eigentümer 1 Beteiligung
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Moringa Sponsor, LP, Moringa Partners Ltd, Ilan Levin | 23. Juni 2026 | 10,60% | Änderung | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.